Browsing Tag
Yale School of Medicine
3 posts
Clearmind Medicine receives IRB approval in Israel for Phase 1/2a trial targeting alcohol use disorder
Clearmind Medicine wins IRB nod in Israel for its psychedelic-based AUD trial. Find out how this pivotal study could reshape addiction treatment.
Could this malaria drug become a breakthrough babesiosis cure? Yale and 60 Degrees aim to find out
Find out how 60 Degrees Pharmaceuticals and Yale are working to develop tafenoquine as a treatment for babesiosis, a rising tick-borne disease threat.
Thermo Fisher Scientific launches global CorEvitas adolescent alopecia areata registry to advance real-world research
Thermo Fisher Scientific Inc., a global leader in serving science, has unveiled the international CorEvitas adolescent alopecia areata…